NDC 85237-1868-01 - Excedrin Extra Strength Headache
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1868
- Requested NDC
- 85237-1868-01
- Package NDCs from labels
- 85237-1868-1, 85237-1868-2, 85237-1868-3, 85237-1868-6, 85237-1868-01
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-10-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Excedrin Extra Strength Headache - Select Consumer Group | Select Consumer Group | 2026-10-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1868-1 | ExcedrinExtra Strength Headache | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 3 | |
| 85237-1868-1 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-2 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-2 | ExcedrinExtra Strength Headache | 2 in 1 BLISTER PACK | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-3 | ExcedrinExtra Strength Headache | 25 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 25 | 3 | |
| 85237-1868-3 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-6 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-6 | ExcedrinExtra Strength Headache | 50 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 50 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | NuCare Pharmaceuticals,Inc. | 80c9a58d-98ae-5497-e053-2991aa0a61fb | 2024-06-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 8592e901-9353-6fb6-e053-2a91aa0ad33b | 2024-06-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 86be8920-2f35-fbc3-e053-2991aa0a0015 | 2024-06-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 872365ca-0c6b-550a-e053-2a91aa0ab25a | 2024-06-14 | Warnings | 362O9ITL9D |
| Artificial Tears | POLYVINYL ALCOHOL, POVIDONE | NuCare Pharmaceuticals,Inc. | 9c1c4911-908e-3c3c-e053-2995a90abcfc | 2024-06-14 | Warnings | FZ989GH94E |
| Tukol Max Action Cold, Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Genomma Lab USA | aedce1f9-4902-4c51-92e0-6056196394c2 | 2024-06-14 | Warnings | 362O9ITL9D |
| Pain Relief Regular Strength | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | 613bc633-0426-41a7-aea9-9ff56311b607 | 2024-06-13 | Warnings | M013 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN | Chain Drug Marketing Association | cfaf9495-e654-4dfc-ba23-d2358c3720c4 | 2024-06-13 | Warnings | M013 362O9ITL9D |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | CHAIN DRUG MARKETING ASSOCIATION, INC. | a6a07615-3108-436f-bbce-be7cb89ce456 | 2024-06-13 | Warnings | 308297 3G6A5W338E R16CO5Y76E 362O9ITL9D |
| Aspirin 81 mg Low Dose | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 18ff2df8-ee65-4219-ad93-cf5090bfac2d | 2024-06-13 | Warnings | M013 R16CO5Y76E |
| 8 Hour Pain Relief | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 3ec966f5-bdcb-4bd8-b265-c776ba778f25 | 2024-06-13 | Warnings | 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 9fdbaf5e-f88b-4d18-97df-0b2e8dddf377 | 2024-06-13 | Warnings | M013 362O9ITL9D |
| Aspirin 81 mg Low dose | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | bfb9af64-3195-44bf-bcf3-6b36b40d3cc7 | 2024-06-13 | Warnings | M013 R16CO5Y76E |
| 8 Hour Arthritis Pain | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | b098ebf6-a76d-4550-b5c4-fdc3b4ceb9a8 | 2024-06-13 | Warnings | 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 1ac7ed71-5afe-d09c-e063-6294a90a3b88 | 2024-06-13 | Warnings | M013 362O9ITL9D |
| Pain Relief PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 3ce5bbf2-d449-464e-abeb-5c26866d1ab5 | 2024-06-13 | Warnings | M013 362O9ITL9D |
| Aspirin | ASPIRIN | AAA Pharmaceutical, Inc. | 609948d6-0f20-4d0c-adc0-6ae72a4f2b7a | 2024-06-13 | Warnings | M013 R16CO5Y76E |
| Aspirin | ASPIRIN | AAA Pharmaceutical, Inc. | 3f73a359-59d7-47bb-872e-914b0db719af | 2024-06-13 | Warnings | M013 R16CO5Y76E |
| 8HR Muscle Aches and Pain | ACETAMINOPHEN | AAA Pharmaceutical, Inc. | 15abb899-e301-40e6-e063-6294a90a4bac | 2024-06-13 | Warnings | 362O9ITL9D |
| Stay Awake | CAFFEINE | AAA Pharmaceutical, Inc. | 14967dc9-d223-d954-e063-6394a90aa676 | 2024-06-13 | Warnings | 3G6A5W338E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.